Approved by the Board on: 30 September 2020
The Board agrees that COVID-19 continues to pose a grave threat to the Global Fund’s mission to fight HIV/AIDS, tuberculosis, and malaria and strengthen systems for health, and that continued support for country responses to COVID-19 is critical to safeguard Global Fund programs and country health systems. The Board acknowledges its previous decisions establishing the Global Fund COVID-19 Response Mechanism (C19RM) to provide additional support for country responses to COVID-19 (GF/B42/EDP11), and approving certain time-bound operational flexibilities to ensure the continued delivery of the Global Fund mission during the pandemic (GF/B42/EDP10). Noting that COVID-19 continues to jeopardize country health systems and impede progress in the Global Fund’s mission, and that additional funds may become available for C19RM, the Board:
Budgetary implications (included in, or additional to, OPEX budget): Incremental OPEX costs directly attributable to the proposed extension of C19RM will amount to around USD 1.5 million, depending to some extent on the quantum of incremental funds deployed over the period. These costs will be included in the OPEX budget submission for 2021. This is on top of approximately USD 2.4 million of incremental costs in 2021 attributable to C19RM and grant flexibility approvals already made.